FDA Drug Recalls

Recalls / Class III

Class IIID-1541-2022

Product

Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC. East Brunswick, NJ 08816. NDC# 29300-137-01

Brand name
Clonidine Hydrochloride
Generic name
Clonidine Hydrochloride
Active ingredient
Clonidine Hydrochloride
Route
Oral
NDCs
29300-136, 29300-468, 29300-137, 29300-135
FDA application
ANDA078895
Affected lot / code info
Lot # GCLH22005, exp. date 02/29/2024

Why it was recalled

Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,

Recalling firm

Firm
UNICHEM PHARMACEUTICALS USA INC
Manufacturer
Unichem Pharmaceuticals (USA), Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Tower Center Blvd Ste 2200, N/A, East Brunswick, New Jersey 08816-1145

Distribution

Quantity
18,960 bottles of 100
Distribution pattern
Distributed Nationwide in the USA

Timeline

Recall initiated
2022-09-19
FDA classified
2022-09-22
Posted by FDA
2022-09-28
Terminated
2023-03-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1541-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.